Gene therapy approaches for DMD have been effectively applied in dystrophic animal models by either directly targeting a class of mutations, as with exon skipping or gene editing,2, 3, 4, 5 or by delivering a synthetic version of the dystrophin or utrophin gene.6 Here, DMD is linked to Duchenne muscular dystrophy.